In summary, the current study demonstrated that downregulation of HMGB2 decreased the infarct size, inflammatory responses, and apoptosis in cerebral injury and had neuroprotective effects against cerebral infarction-induced brain damage. The gene discussed is HMGB2; the disease is brain infarction.